Related Experiment Videos
Plasma fibronectin level in patients with functional thyroid adenoma
Acta Medica Austriaca
|January 1, 1990
Summary
Plasma fibronectin levels indicate thyroid hormone effects in tissues. In preclinical hyperthyroidism, inverse relationships suggest suppressed TSH may be harmful long-term.
Area of Science:
- Endocrinology
- Biochemistry
- Molecular Biology
Background:
- Thyroid hormones regulate numerous physiological processes.
- Peripheral markers are needed to assess thyroid hormone action.
- Fibronectin is a key extracellular matrix protein involved in cellular functions.
Purpose of the Study:
- To investigate plasma fibronectin (pFn) as a marker of thyroid hormone action at the tissue level.
- To explore the relationship between pFn and thyroid-stimulating hormone (TSH) in preclinical hyperthyroidism.
Main Methods:
- Measurement of plasma fibronectin levels.
- Assessment of serum TSH concentrations.
- Analysis of patient cohorts with varying thyroid hormone status.
Main Results:
- Plasma fibronectin levels show sensitivity, but not specificity, as a marker for thyroid hormone effects in peripheral connective tissues.
- An inverse correlation between pFn and serum TSH was observed in patients with preclinical hyperthyroidism.
- This inverse relationship suggests excessive thyroid hormone action at the target organ level.
Conclusions:
- Plasma fibronectin may serve as a useful indicator of peripheral thyroid hormone activity.
- Suppressed TSH secretion in preclinical hyperthyroidism might have long-term detrimental effects.
- These findings have potential therapeutic implications for managing thyroid disorders.